Jason Szelog, MD
Ophthalmology · Portsmouth, NHNPI 1366936882
Payments from drug & device makers
Across 126 payments — averaging $566.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron$65K
- Bausch & Lomb, A Division Of Bausch Health US, LLC$2K
- Alcon$995
- Regeneron Healthcare Solutions, Inc.$846
- Apellis Pharmaceuticals, Inc.$400
- Genentech USA, Inc.$301
- plus $2K from 18 others
What the payments were for
- Grants$65,00091%
- Travel & lodging$1,3622%
- Food & beverage$4,9487%
- Education$1210%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron | 26 | $65,000 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 19 | $1,692 |
| Alcon | 14 | $995 |
| Regeneron Healthcare Solutions, Inc. | 17 | $846 |
| Apellis Pharmaceuticals, Inc. | 8 | $400 |
| Genentech USA, Inc. | 4 | $301 |
| Harrow Eye, LLC | 1 | $291 |
| Astellas Pharma US Inc | 9 | $283 |
| Amgen(2 entities) | 3 | $203 |
| AbbVie(2 entities) | 5 | $191 |
| Alimera Sciences, Inc. | 4 | $166 |
| Rxsight Inc | 1 | $145 |
| Beaver-visitec International, Inc. | 1 | $144 |
| Dompe US, Inc. | 1 | $125 |
| Sun Pharmaceutical Industries Inc. | 1 | $117 |
| Genentech, Inc. | 1 | $103 |
| Sight Sciences, Inc. | 2 | $97 |
| Stryker | 1 | $96 |
| Novartis | 1 | $87 |
| ANI Pharmaceuticals, Inc. | 3 | $62 |
| Biogen | 1 | $26 |
| Oyster Point Pharma, Inc. | 1 | $22 |
| Bausch & Lomb Americas Inc. | 1 | $21 |
| Ocular Therapeutix, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- STELLARIS$1,098
- Crystalens Accommodating IOL (AT-52AO)$1,098
- Trulign IOL$1,098
- Akreos AO IOL$1,098
- enVista MX60 IOL$1,098
- EYLEA HD$366
- VABYSMO$354
- IHEEZO$291
- AcrySof$243
- NGENUITY$146
- RXSIGHT CONTACT LENS$145
- RXSIGHT INJECTOR CARTRIDGE$145
- RXSIGHT INJECTOR HANDPIECE$145
- RXSIGHT LIGHT DELIVERY DEVICE (LDD)$145
- LIGHT ADJUSTABLE LENS (LAL)$145
- Oxervate$125
- Precision 1$123
- TEPEZZA$122
- CEQUA$117
- EYLEA$112
How this compares
$71,430 in reported general payments places this provider in the 95th percentile of 80 ophthalmology providers in New Hampshire.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CombiganBrimonidine Tartrate/Timolol | 12 | $3,884 |
| Prednisolone Acetate | 59 | $2,893 |
| Ketorolac Tromethamine | 75 | $2,616 |
| Latanoprost | 134 | $976 |
| Brimonidine Tartrate | 44 | $636 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 37 | $566 |
| MoxifloxacinMoxifloxacin Hcl | 15 | $427 |
| Timolol Maleate | 47 | $405 |
| Dorzolamide Hcl | 31 | $388 |
| ErythromycinErythromycin Base | 28 | $261 |
| Diclofenac Sodium | 18 | $249 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 18 | $185 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieCombigan | $191 | $3,88412 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 80 ophthalmology providers in New Hampshire.
Other ophthalmology in Portsmouth
- Newton PetersPortsmouth$195K
- Jennifer LingPortsmouth$9K
- Claudia BartoliniPortsmouth$4K
- Warren GoldblattPortsmouth$3K
- Timothy SullivanPortsmouth$3K
- Lucian SzmydPortsmouth$2K
- Richard LasondePortsmouth$1K
- Nathaniel SearsPortsmouth$601
- Marsha KavanaghPortsmouth$371
- Dane SlentzDerry$127K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.